Oxford BioMedica plc  

(Public, LON:OXB)   Watch this stock  
Find more results for OXB
-0.25 (-2.38%)
May 22 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range 10.25 - 10.75
52 week 1.91 - 13.38
Open 10.50
Vol / Avg. 0.00/4.17M
Mkt cap 263.47M*
P/E     -
Div/yield     -
EPS 0.00*
Shares 2.57B
Beta     -
Inst. own     -
Jun 16, 2015
Oxford BioMedica PLC Annual Shareholders Meeting (Estimated) - 10:00AM GMT+1 - Add to calendar
May 7, 2015
Oxford BioMedica PLC Annual Shareholders Meeting
Mar 9, 2015
Oxford BioMedica PLC at ROTH Conference

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -43.41% -63.60%
Operating margin -58.43% -77.93%
EBITD margin - -69.86%
Return on average assets -24.17% -36.51%
Return on average equity -32.53% -54.24%
Employees 113 -
CDP Score - -


Windrush Court,Transport Way
United Kingdom - Map
+44-1865-783000 (Phone)
+44-1865-783001 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Oxford Biomedica PLC is a United Kingdom-based biopharmaceutical company. The Company is engaged in advanced therapy medicinal products. The Company designs, develops and manufactures gene-based medicines and therapeutic vaccines. The Company's technology platform includes LentiVector gene delivery technology, which has specific advantages for targeting diseases of the eye and central nervous system and a tumour antigen (5T4), which is a target for anti-cancer therapy. Its product pipeline addresses diseases, including ocular diseases, neurodegenerative disorders and cancer.

Officers and directors

John Dawson Chief Executive Officer, Executive Director
Age: 55
Tim Watts Chief Financial Officer, Company Secretary, Executive Director
Age: 57
Paul Blake M.D. Executive Director, Chief Development Officer
Age: 66
Peter Nolan Executive Director, Chief Business Officer
Age: 62
Nicholas Rodgers Non-Executive Independent Chairman of the Board
Age: 56
Andrew J. Heath M.D., Ph.D. Non-Executive Deputy Chairman of the Board, Senior Independent Director
Age: 66
Martin Diggle Non-Executive Director
Age: 52
Daniel B. Soland Non-Executive Director
Age: 54